This guest post comes courtesy of Jason Bloomberg, managing partner atZapThink. Take the BriefingsDirect middleware/ESB survey now. On the other hand, there are plenty of enterprise architects who do ...
Isomorphic Labs, Google’s artificial intelligence drug business, raised $600 million in its first external funding round, the company said on Monday. Thrive Capital, a venture capital firm, led the ...
Isomorphic Labs was spun out of DeepMind in 2021 as a commercial venture, aiming to 'reimagine' the entire drug discovery process Isomorphic Labs, a subsidiary of Google parent Alphabet that uses ...
Isomorphic Labs Inc., a healthcare startup that spun out of Alphabet Inc. in 2021, today announced that it has closed a $600 million funding round. OpenAI backer Thrive Capital led the investment. It ...
Google parent Alphabet has drawn on its DeepMind artificial intelligence division to form a drug discovery unit that it calls Isomorphic Labs. The UK-registered company will be able to tap into ...
Last year, Alphabet’s DeepMind announced its AlphaFold 2 AI showed it could predict how certain proteins would fold in a way that was competitive with experimental data. The news was met with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results